-
Mounjaro Weight Loss Prescription: Myth or Miracle?
FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]
-
Understanding Metabolic Weight Loss: Exploring the Science Behind It
Introduction Metabolic weight loss has emerged as a popular approach to shedding unwanted pounds and achieving sustainable weight loss. Unlike traditional weight loss methods that focus solely on calorie restriction, metabolic weight loss emphasizes understanding the intricate […]
-
Semaglutide Dosing for Weight Loss: What You Need to Know
Introduction to Semaglutide Dosing Semaglutide (the active ingredient in Wegovy® and Ozempic®)[1] is a medication initially developed for the management of type 2 diabetes. Lately, it has emerged as a promising agent in the realm of weight […]
-
How an Online Weight Loss Prescription Can Change the Game
Introduction An online weight loss prescription has emerged as a convenient an accessible option for individuals seeking professional guidance in their weight loss journey. In recent years, these virtual platforms have gained significant popularity. Their convenience, ease […]
-
Mistakes to Avoid When Trying Mounjaro® Dosing for Weight Loss
FDA notice on Zepbound™/Mounjaro® shortage: The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has ended. Schedule a visit with an Ivim provider to discuss what this […]
-
Why Choose Liraglutide?
Liraglutide (the active ingredient in Saxenda®)[1] and semaglutide (the active ingredient in Wegovy® and Ozempic®)[2] are both medications that belong to the same class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Saxenda® (liraglutide), Wegovy® (semaglutide) is […]
-
Benefits of Liraglutide
Obesity is a growing health concern worldwide, and it is associated with an increased risk of developing several chronic diseases, including type 2 diabetes, heart disease, and certain types of cancer. While diet and exercise are the […]
-
Semaglutide vs Liraglutide
Liraglutide (the active ingredient in Saxenda®)[1] and semaglutide (the active ingredient in Wegovy® and Ozempic®)[2] are two GLP-1 receptor agonists used to manage type 2 diabetes. The primary difference between the two GLP-1 medications is the dosage […]
-
Semaglutide FAQs
What is Semaglutide?Semaglutide (the active ingredient in Novo Nordisk’s Ozempic® and Wegovy® drug products)– is an injectable medication which, when used in combination with diet and exercise, helps with blood sugar control, appetite control, and potential weight […]
-
The Newly Approved “Game Changer” Weight Loss Drug
The most effective drug intervention for the treatment of obesity is now available and has acclaimed the label “weight loss wonder drug” and a “game changer” weight loss solution. In a recently published study in the New […]
Services
Company
Support
Legal
